Coverage of high-potential mid-market firms in Poland

Article

Bioton biotech posts PLN 3.9 mln net loss in Q4 2013

TAG'S: BIOTON, Services (other)

 

Listed biotech firm Bioton posted a Q4 2013 attributable net loss of PLN 3.9 mln, as compared to a PLN 15.1 mln loss in the prior-year period, the firm`s financial report out Friday post-session showed.

Bioton recorded a gross operating profit of PLN 4.1 mln, up from PLN 1.9 mln in the year-prior period, the report showed.

 Group revenues in Q4 amounted to PLN 93.1 mln, up slightly from PLN 88.8 mln in Q4 2012.

Also, Bioton signed a letter of intent on selling its 50% stake in medical equipment producer Copernicus to the firm`s other shareholders for PLN 25 mln, the firm said in a market filing.

 

The transaction conclusion, subject to a number of conditions, is expected by March 31, 2014.

2014-02-15



Comments : 0

Add comment

The published comments are private opinions of the users. Biznespolska Media Sp. z o.o. is not responsible for their content. Intelligent and insightful comments most appreciated.

Other News

Photo of the week

Photo of the week

Following an impressive run, PKN Orlen fuel reappoints CEO Wojciech Jasiński to spearhead the company to newer, more challenging waters. Gives him a new three year term!

2017-11-21

WSE Indices


NameValueChangeTime
WIG20 2468,32 +0,01 % 10:54
WIG 63596,36 -0,04 % 10:40
sWIG80 14039,26 +0,06 % 10:40
NCIndex 285,49 +0,08 % 10:40
2017-11-21

WSE Companies


Top 5 Gainers

NameValueChange
VISTULA GROUP3,97+8,47 %
DROZAPOL-PROFIL2,00+7,53 %
MEX POLSKA4,74+6,76 %
INTERFERIE3,60+6,82 %
BYTOM2,62+5,22 %

Top 5 Losers

NameValueChange
QUMAK1,29-7,86 %
INTER CARS264,80-6,10 %
IZOBLOK SPOLKA AKCYJNA103,20-5,32 %
SWISSMED CENTRUM ZDROWIA0,82-5,75 %
AWBUD SA4,50-4,05 %